Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Clinical Approach for the Treatment of Obesity-associated Diseases

Author(s): Esma R. Isenovic

Volume 25, Issue 18, 2019

Page: [2017 - 2018] Pages: 2

DOI: 10.2174/138161282518190822153931

Next »
[1]
Gouni-Berthold I, Berthold HK. Current options for the pharmacotherapy of obesity. Curr Pharm Des 2019; 25(18): 2019-32.
[2]
Radak D, Tanaskovic S, Neskovic M. The obesity-associated risk in open and endovascular repair of abdominal aortic aneurysm. Curr Pharm Des 2019; 25(18): 2033-7.
[3]
Cӑtoi AF, Vodnar DC, Corina A, et al. Gut microbiota, obesity and bariatric surgery: Current knowledge and future perspectives. Curr Pharm Des 2019; 25(18): 2038-50.
[4]
Katsiki N, Anagnostis P, Kotsa K, Goulis DG, Mikhailidis DP. Current options for the pharmacotherapy of obesity. Curr Pharm Des 2019; 25(18): 2051-9.
[5]
Tan Y, Chen S, Zhong J, Ren J, Dong M. Mitochondrial injury and targeted intervention in septic Cardiomyopathy. Curr Pharm Des 2019; 25(18): 2060-70.
[6]
Joksić G, Tričković JF, Joksić I. Potential of Gentiana lutea in treatment of obesity-associated diseases. Curr Pharm Des 2019; 25(18): 2071-6.
[7]
Yu W, Zha W, Peng H, Wang Q, Zhang S, Ren J. Trehalose protects against insulin resistance-induced tissue injury and excessive autophagy in skeletal muscles and kidney. Curr Pharm Des 2019; 25(18): 2077-85.

Rights & Permissions Print Cite
Article Metrics
33
3
© 2024 Bentham Science Publishers | Privacy Policy